A new study finds IVIG treatments improved symptoms for up to 46 weeks in certain patients. Intravenous immunoglobulin is often used as a treatment for PANS, and a study looked at the efficacy of the treatment over a six-month period. The study found statistically significant reductions in symptoms from the start of treatment to the… Continue reading Extended Intravenous Immunoglobulin Treatment Shows Efficacy in 21 PANS Youth Over 6 months
And why many doctors do not realize it Read paper full paper here.
A new study shows marked improvement for at least one year in PANDAS/PANS symptoms following IVIG treatment. A new study of PANDAS/PANS patients in Italy published in NeuroSci found that IVIG treatment resulted in a noticeable improvement in symptoms for children with PANDAS/PANS. The study included 55 patients with extreme severity of PANDAS/PANS, according to… Continue reading 55 PANS Youth Receive IVIG Treatment with Dramatic Symptom Improvement in Majority (Italian Study)
A subcommittee of the Autoimmune Encephalitis International Working Group developed new guidelines for recognizing autoimmune encephalitis that includes PANS in children. A subcommittee of the Autoimmune Encephalitis International Working Group developed new guidelines for recognizing autoimmune encephalitis that includes PANS in children. PANDAS/PANS is a form of Autoimmune Encephalitis (AE), but recognizing the disease in… Continue reading 2020 Guidelines for Autoimmune Encephalitis in Children Including PANS Diagnosis
The majority of respondents felt the pandemic negatively impacted their child’s friendships, relationships with extended family, hobbies, and academic skills. Children with suspected or diagnosed COVID-19 experienced new or worsened existing symptoms, particularly mood lability, OCD, and anxiety Read full paper here